(Q35571481)

8 August 2017

title

Drug reimbursement in Finland-a case of explicit prioritizing in special categories (English)

1 reference

8 August 2017

Drug reimbursement in Finland—a case of explicit prioritising in special categories (English)

1 reference

https://api.crossref.org/works/10.1016/S0168-8510(03)00042-3

26 March 2024

0 references

1 reference

health insurance reimbursement

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585516

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0168-8510(03)00042-3

26 March 2024

author name string

Lauri Vuorenkoski

series ordinal

1

1 reference

8 August 2017

Hanna Toiviainen

series ordinal

2

1 reference

8 August 2017

Elina Hemminki

series ordinal

3

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585516

26 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0168851003000423?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0168-8510(03)00042-3

https://api.elsevier.com/content/article/PII:S0168851003000423?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0168-8510(03)00042-3

26 March 2024

1 reference

8 August 2017

volume

66

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

169-177

1 reference

Science, medicine, and the future: Bioinformatics

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Selling sickness: the pharmaceutical industry and disease mongering

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

1 reference

7 January 2021

The rationing debate. Rationing within the NHS should be explicit. The case for.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Explicit and implicit rationing: taking responsibility and avoiding blame for health care choices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Priority-setting in Finnish healthcare

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Stakeholder analysis: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

A stakeholder analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Fair conduct and fair reporting of clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Drug Reimbursement in Four Nordic Countries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Who wants to know if their care is rationed? Views of citizens and service informants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

The second phase of priority setting. Goodbye to the simple solutions: the second phase of priority setting in health care

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Efficiency and equity of health care systems

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Health economists meet the fourth tempter: drug dependency and scientific discourse.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Involving the public in rationing decisions. The experience of citizens juries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Public participation and the moral quality of healthcare rationing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Opinions of Swedish citizens, health-care politicians, administrators and doctors on rationing and health-care financing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

An inquiry into associations between leading physicians and the drug industry in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Fairness, accountability for reasonableness, and the views of priority setting decision-makers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2803%2900042-3

7 January 2021

Identifiers

1 reference

8 August 2017

1 reference